 Evogene Ltd. NASDAQ: EVGN TASE: EVGN.TA, a leading biotechnology company aiming to revolutionize the development of novel products for life-science based industries by utilizing cutting edge computational biology technologies, announces today that it will release its financial results for the first quarter 2020 on Tuesday, May 26, 2020. 